You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石四藥(02005.HK):將加緊生產以全力保障各地用藥需求
阿思達克 01-03 17:02
石四藥(02005.HK)集團表示,近期市場需求出現變化,集團旗下抗病毒、消炎、止咳祛痰類輸液及水針產品需求大增,供不應求,現時正全力保障鹽酸莫西沙星氯化鈉注射液、鹽酸氨溴索氯化鈉注射液和鹽酸溴己新氯化鈉注射液、對乙醯氨基酚甘露醇注射液等抗菌消炎、止咳、退熱、抗病毒重點輸液和水針產品的生產和市場供應。 集團指,旗下石家莊生產廠區的輸液和水針製劑車間正在加緊生產各類輸液和安瓿水針產品,近30條輸液和安瓿水針生產線全部開滿,工人正全力以赴趕製訂單。其中,鹽酸氨溴索注射液冬春季節臨床用量較大,現時正是銷售旺季,加上農曆新年將至,不少客戶都提前預付貨款,訂單計劃已排滿。 為盡快提升產能,集團及時調整和整合採購、生產、質量、銷售、運輸等環節,組織骨幹力量充實到生產、質量、技術等關鍵崗位,加大原輔料等採購和儲備,車間及時增加班次,以確保產品優質出廠、產銷不斷檔,相信相關藥品的產能將得到釋放,有效保障各地用藥需求。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account